Allosteric inhibition of protein tyrosine phosphatase 1B |
| |
Authors: | Wiesmann Christian Barr Kenneth J Kung Jenny Zhu Jiang Erlanson Daniel A Shen Wang Fahr Bruce J Zhong Min Taylor Lisa Randal Mike McDowell Robert S Hansen Stig K |
| |
Affiliation: | Sunesis Pharmaceuticals, 341 Oyster Point Boulevard, South San Francisco, California 94080, USA. |
| |
Abstract: | Obesity and type II diabetes are closely linked metabolic syndromes that afflict >100 million people worldwide. Although protein tyrosine phosphatase 1B (PTP1B) has emerged as a promising target for the treatment of both syndromes, the discovery of pharmaceutically acceptable inhibitors that bind at the active site remains a substantial challenge. Here we describe the discovery of an allosteric site in PTP1B. Crystal structures of PTP1B in complex with allosteric inhibitors reveal a novel site located approximately 20 A from the catalytic site. We show that allosteric inhibitors prevent formation of the active form of the enzyme by blocking mobility of the catalytic loop, thereby exploiting a general mechanism used by tyrosine phosphatases. Notably, these inhibitors exhibit selectivity for PTP1B and enhance insulin signaling in cells. Allosteric inhibition is a promising strategy for targeting PTP1B and constitutes a mechanism that may be applicable to other tyrosine phosphatases. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|